Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pidotimod oral solution in pediatric recurrent respiratory tract infection
CTR20200056Phase 4Active
- Sponsor
- Jiangsu Wuzhong Pharmaceutical Development
- Start
- Jan 2020
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of pidotimod in Airways Infection, sponsored by Jiangsu Wuzhong Pharmaceutical Development. Started Jan 2020; status: active.
02
Drugs
pidotimod
03
Conditions
Airways Infection
Beyond the preview
Go deeper on CTR20200056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200056.